Galmed Pharmaceuticals
GLMD
#10633
Rank
S$4.89 M
Marketcap
S$0.74
Share price
-3.32%
Change (1 day)
-58.44%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Galmed Pharmaceuticals CIK: 0001595353
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Galmed Pharmaceuticals only files 20-F reports

Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2026-03-31

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2025-04-02

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2024-04-04

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2023-03-29

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2022-05-02

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2021-03-18

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2020-03-12

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2019-03-13

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2018-03-13

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2017-03-23

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2016-03-22

Language: English

View Annual Report (20-F)
Thumbnail Galmed Pharmaceuticals
 20-F Annual Report

20-F Annual Report 2015-03-31

Language: English

View Annual Report (20-F)